Immunotherapy Treating GI Cancer
NCT03614650
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
BIOLOGICAL:
engineered immune cells
Sponsor
Shenzhen Geno-Immune Medical Institute